Cytokine implicated in HLH treatment resistance

Research sheds light on cytokine storm syndromes and how ruxolitinib may benefit patients with hemophagocytic lymphohistiocytosis.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200612111421.htm